Wegovy maker sues Hims & Hers
Digest more
Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and HHS. The company now faces a lawsuit from Novo Nordisk for patent infringement of its Wegovy pill.
This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more
Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
WASHINGTON — Novo Nordisk's weight-loss pill is now offered through Amazon's digital pharmacy. The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral option to the weekly injectable drug.